Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Denver Anschutz Medical Campus, Aurora, Colorado, USA.
Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado, USA.
Hepatology. 2024 May 1;79(5):986-1004. doi: 10.1097/HEP.0000000000000690. Epub 2023 Nov 16.
Parenteral nutrition-associated cholestasis (PNAC) is an important complication in patients with intestinal failure with reduced LRH-1 expression. Here, we hypothesized that LRH-1 activation by its agonist, dilauroylphosphatidylcholine (DLPC), would trigger signal transducer and activator of transcription 6 (STAT6) signaling and hepatic macrophage polarization that would mediate hepatic protection in PNAC.
PNAC mouse model (oral DSSx4d followed by PNx14d; DSS-PN) was treated with LRH-1 agonist DLPC (30 mg/kg/day) intravenously. DLPC treatment prevented liver injury and cholestasis while inducing hepatic mRNA expression of Nr5a2 (nuclear receptor subfamily 5 group A member 2), Abcb11 (ATP binding cassette subfamily B member 11), Abcg5 (ATP-binding cassette [ABC] transporters subfamily G member 5), Abcg8 (ATP-binding cassette [ABC] transporters subfamily G member 8), nuclear receptor subfamily 0, and ATP-binding cassette subfamily C member 2 ( Abcc2) mRNA, all of which were reduced in PNAC mice. To determine the mechanism of the DLPC effect, we performed RNA-sequencing analysis of the liver from Chow, DSS-PN, and DSS-PN/DLPC mice, which revealed DLPC upregulation of the anti-inflammatory STAT6 pathway. In intrahepatic mononuclear cells or bone-marrow derived macrophages (BMDM) from PNAC mice, DLPC treatment prevented upregulation of pro-inflammatory (M1) genes, suppressed activation of NFκB and induced phosphorylation of STAT6 and its target genes, indicating M2 macrophage polarization. In vitro, incubation of DLPC with cultured macrophages showed that the increased Il-1b and Tnf induced by exposure to lipopolysaccharides or phytosterols was reduced significantly, which was associated with increased STAT6 binding to promoters of its target genes. Suppression of STAT6 expression by siRNA in THP-1 cells exposed to lipopolysaccharides, phytosterols, or both resulted in enhanced elevation of IL-1B mRNA expression. Furthermore, the protective effect of DLPC in THP-1 cells was abrogated by STAT6 siRNA.
These results indicate that activation of LRH-1 by DLPC may protect from PNAC liver injury through STAT6-mediated macrophage polarization.
肠衰竭患者发生肠外营养相关性胆汁淤积症(PNAC)与 LRH-1 表达减少有关。本研究假设 LRH-1 激动剂二软脂酰磷脂酰胆碱(DLPC)可激活信号转导和转录激活因子 6(STAT6)信号通路,并诱导肝内巨噬细胞极化,从而减轻 PNAC 中的肝损伤。
采用口服 DSSx4d 联合 PNx14d(DSS-PN)建立 PNAC 小鼠模型,用静脉注射 LRH-1 激动剂 DLPC(30mg/kg/天)处理。DLPC 治疗可预防肝损伤和胆汁淤积,并诱导 Nr5a2(核受体亚家族 5 组 A 成员 2)、Abcb11(ATP 结合盒亚家族 B 成员 11)、Abcg5(ATP 结合盒[ABC]转运子亚家族 G 成员 5)、Abcg8(ATP 结合盒[ABC]转运子亚家族 G 成员 8)、核受体亚家族 0 和 ATP 结合盒亚家族 C 成员 2(Abcc2)mRNA 在肝内的表达,而这些在 PNAC 小鼠中均减少。为确定 DLPC 作用的机制,我们对 Chow、DSS-PN 和 DSS-PN/DLPC 小鼠的肝组织进行了 RNA 测序分析,结果显示 DLPC 上调了抗炎性的 STAT6 通路。在 PNAC 小鼠的肝内单核细胞或骨髓来源的巨噬细胞(BMDM)中,DLPC 治疗可预防促炎性(M1)基因的上调,抑制 NFκB 的激活,并诱导 STAT6 及其靶基因的磷酸化,表明 M2 巨噬细胞极化。在体外,用 DLPC 孵育培养的巨噬细胞后,发现由 LPS 或植物固醇暴露引起的 Il-1b 和 Tnf 显著增加,而这与 STAT6 结合其靶基因启动子的增加有关。用 LPS、植物固醇或两者联合作用于 THP-1 细胞后,用 siRNA 抑制 STAT6 表达,导致 IL-1B mRNA 表达的显著升高。此外,DLPC 在 THP-1 细胞中的保护作用被 STAT6 siRNA 所阻断。
这些结果表明,DLPC 激活 LRH-1 可能通过 STAT6 介导的巨噬细胞极化来保护 PNAC 肝损伤。